Mounjaro Vial vs Pen UK - Compare Prices & Options

Clinically Proven UK Registered Pharmacy

Mounjaro Vial vs Pen - Compare UK Prices & Options

Compare formats from £124.99 with £20 off first order using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Mounjaro Vial vs Pen: Understanding Your Tirzepatide Delivery Options in the UK

Published: 11 September 2026

When considering mounjaro vial vs pen for weight loss treatment, UK patients often wonder which tirzepatide delivery format offers better convenience, value, and clinical outcomes. Mounjaro is currently available in the UK exclusively as a pre-filled KwikPen device, while vial formulations remain unavailable through licensed UK pharmacies. Understanding the differences between these formats helps patients make informed decisions about their weight management journey under the guidance of a UK-registered prescriber.

What Is the Difference Between Mounjaro Vial vs Pen Formats?

The mounjaro vial vs pen comparison centres on delivery mechanism and preparation requirements. A vial format would contain tirzepatide solution requiring manual drawing into a syringe before injection, whilst the KwikPen is a pre-filled, single-use injection device requiring no preparation. The pen format incorporates a hidden needle, dose selector dial, and automatic injection mechanism designed for patient convenience and dosing accuracy[1].

In clinical practice, pre-filled pen devices like the Mounjaro KwikPen reduce preparation errors, eliminate the need for separate syringes and needles, and provide consistent dosing through a controlled injection mechanism. Vial formulations, whilst common for some medications, introduce additional steps that may increase contamination risk and dosing variability. The SURPASS clinical trial programme exclusively used pen-format tirzepatide, establishing the evidence base for this delivery method[2].

UK regulatory approval through the MHRA covers only the KwikPen format, ensuring patients receive a licensed, quality-assured product with established safety data. At Cured Pharmacy, Mounjaro is available from £124.99 as a pre-filled KwikPen following online clinical assessment by our UK-registered prescribers.

Mounjaro Vial vs Pen: UK Availability and Regulatory Status

When evaluating mounjaro vial vs pen availability in the UK, it's essential to understand that only the KwikPen format holds MHRA licensing for weight management. Tirzepatide vials are not currently licensed or commercially available through legitimate UK pharmacies, meaning patients seeking this medication must use the approved pen device[3].

The regulatory distinction matters significantly for patient safety and treatment efficacy. Licensed medicines undergo rigorous quality control, stability testing, and post-market surveillance by the MHRA. Unlicensed vial formulations obtained through unregulated channels lack these safeguards and may pose serious health risks including contamination, incorrect dosing, or counterfeit ingredients.

Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensures all Mounjaro prescriptions dispensed through Cured Pharmacy meet full UK regulatory standards. Patients complete a clinical assessment under three minutes, with prescriptions issued only when clinically appropriate by our UK-registered medical team. This process guarantees genuine, licensed tirzepatide in the approved KwikPen format.

Why Vial Formats Aren't Available in UK Pharmacies

The absence of licensed Mounjaro vials in the UK reflects manufacturer strategy and regulatory pathways. Eli Lilly developed tirzepatide specifically as a pen-delivered therapy, investing in device technology that optimises patient adherence and clinical outcomes. The company has not pursued UK licensing for vial formulations, focusing instead on the KwikPen platform proven in clinical trials. Patients seeking mounjaro vial vs pen comparisons should prioritise the licensed, evidence-based option available through registered UK pharmacies.

Mounjaro Vial vs Pen: Convenience and Ease of Use Comparison

The mounjaro vial vs pen debate often centres on practical usability for patients managing weekly injections. The KwikPen offers significant convenience advantages: pre-measured doses eliminate calculation errors, the device is portable and discreet, and the injection process requires minimal training. Patients simply attach a new needle, dial the prescribed dose, and inject subcutaneously—typically completed in under 30 seconds[4].

Vial-based administration would require patients to draw precise volumes using a separate syringe, manage multiple components (vial, syringes, needles, alcohol swabs), and ensure proper storage and disposal. This complexity increases the risk of dosing errors, particularly for patients unfamiliar with injectable medications. Research demonstrates that pre-filled pen devices improve adherence rates by 15-20% compared to vial-and-syringe methods in chronic disease management.

The Mounjaro KwikPen's ergonomic design includes tactile and audible feedback confirming dose delivery, reducing anxiety around self-injection. The device stores safely at room temperature for up to 21 days after first use, offering flexibility for travel and daily routines. These practical benefits contribute to sustained treatment adherence, which directly correlates with weight loss outcomes in clinical studies.

Training and Support for Pen Injection Technique

When starting Mounjaro treatment through Cured Pharmacy, patients receive comprehensive injection guidance as part of their clinical consultation. Our prescribers provide detailed instructions on KwikPen technique, injection site rotation (abdomen, thigh, or upper arm), and troubleshooting common concerns. This support structure, combined with the pen's intuitive design, ensures patients feel confident managing their weekly injections from the first dose.

Feature Mounjaro Vial Mounjaro KwikPen
UK Availability Not licensed/available Fully licensed (MHRA)
Preparation Required Manual drawing with syringe Pre-filled, ready to use
Dosing Accuracy Variable (user-dependent) Fixed, precise doses
Convenience Multiple components needed Single-use device
Clinical Trial Data None in UK SURPASS programme (6,000+ patients)
Starting Price at Cured N/A From £145.00
Storage Refrigeration required Room temp up to 21 days after first use
Safety Features Basic Needle shield, dose confirmation

Mounjaro Vial vs Pen: Cost Considerations for UK Patients

Price comparison in the mounjaro vial vs pen discussion is straightforward in the UK context: only the KwikPen format is available through licensed channels. At Cured Pharmacy, Mounjaro KwikPen starts from £124.99 per dose, with transparent pricing displayed before consultation. New patients receive £20 off their first order using code Weightlossnew, making initial treatment more accessible.

Theoretical vial pricing is difficult to assess given the lack of UK availability, but international markets suggest vials might offer marginal cost savings offset by additional expenses for syringes, needles, and disposal containers. However, these comparisons are academic for UK patients who must prioritise licensed, regulated medicines. Purchasing unlicensed vials through unregulated sources poses legal and safety risks far outweighing any potential savings.

The value proposition of the KwikPen extends beyond unit cost to encompass reduced waste (precise dosing prevents medication loss), fewer injection complications (consistent technique), and better long-term adherence (convenience supports sustained use). Clinical trial data from the SURPASS-2 study showed participants achieved average weight loss of 15-22.5% over 72 weeks using pen-delivered tirzepatide, demonstrating the format's effectiveness[2].

Mounjaro Vial vs Pen: Clinical Efficacy and Safety Profile

From a clinical perspective, the mounjaro vial vs pen comparison reveals no inherent efficacy differences—the active ingredient, tirzepatide, remains identical regardless of delivery format. However, the delivery method significantly impacts real-world effectiveness through its influence on dosing accuracy and treatment adherence. The SURPASS clinical trial programme exclusively utilised pen-format tirzepatide, meaning all published efficacy data reflects this delivery method[1][2].

Dosing precision matters critically for tirzepatide's dual GIP/GLP-1 receptor agonist mechanism. The medication requires careful dose escalation from 2.5mg to maintenance doses of 5mg, 10mg, or 15mg over 8-20 weeks to minimise gastrointestinal side effects whilst optimising weight loss. The KwikPen's fixed-dose design ensures patients receive exactly the prescribed amount, eliminating under- or over-dosing risks associated with manual syringe drawing.

Safety considerations also favour the pen format. Pre-filled devices reduce contamination risk through sealed, sterile construction, whilst vial-based administration introduces multiple contamination opportunities during drawing and injection. The KwikPen's automatic needle shield protects against needlestick injuries, and the device's disposal as a single unit simplifies sharps management. These safety features align with UK clinical guidelines for injectable medication administration in community settings.

Side Effect Management Across Delivery Formats

Tirzepatide's side effect profile—primarily nausea, diarrhoea, and decreased appetite—remains consistent regardless of delivery format, as these effects relate to the medication's pharmacological action rather than administration method. However, the KwikPen's reliable dosing supports the gradual escalation schedule proven to minimise gastrointestinal symptoms. Patients experiencing side effects receive ongoing support from Cured Pharmacy's clinical team, with dose adjustments made as clinically appropriate to balance efficacy and tolerability.

Mounjaro Vial vs Pen: Making the Right Choice for Your Weight Loss Journey

For UK patients, the mounjaro vial vs pen decision is effectively made by regulatory and availability constraints—the KwikPen represents the only licensed, safe, and legal option. This clarity simplifies treatment planning whilst ensuring patients access a delivery format extensively validated through clinical trials involving over 6,000 participants across the SURPASS programme[2].

The KwikPen format suits the vast majority of patients seeking tirzepatide for weight management. Its convenience supports long-term adherence, the critical factor determining treatment success. Patients who maintain consistent weekly injections over 12+ months achieve substantially greater weight loss than those with irregular dosing patterns. The pen's ease of use directly supports this consistency, particularly for individuals new to injectable medications.

Starting Mounjaro through Cured Pharmacy involves a streamlined online consultation taking under three minutes, followed by discreet home delivery within 24-48 hours. Our UK-registered prescribers assess suitability based on BMI, weight loss history, and medical background, ensuring tirzepatide is clinically appropriate. With pricing from £124.99 and £20 off first orders using code Weightlossnew, patients access competitive UK pricing alongside comprehensive pharmaceutical care from our GPhC-registered team.

Next Steps: Starting Mounjaro Treatment Safely

Patients ready to begin Mounjaro should complete an online clinical assessment through a registered UK pharmacy like Cured Pharmacy (GPhC 9012511). This process ensures prescribing aligns with MHRA guidelines and NICE recommendations for weight management interventions. Following approval, patients receive their KwikPen with full injection instructions, ongoing clinical support, and access to our pharmacist team for any questions throughout treatment. This comprehensive approach maximises both safety and effectiveness for sustainable weight loss outcomes.

Scientific References

  1. Frias, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 11 September 2026]
  2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & SURMOUNT-1 Investigators. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 11 September 2026]
  3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. GOV.UK. [accessed 11 September 2026]
  4. Aronson, R., Orzech, N., Ye, C., & Brown, R. E. (2020). Insulin pen needles: Effects of extra-thin wall needle technology on preference, confidence, and other patient ratings. Clinical Therapeutics, 42(10), 1900-1909. [accessed 11 September 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 11 September 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 11 September 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 11 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can I get Mounjaro in vial format in the UK?
No, Mounjaro vials are not licensed or available through UK pharmacies. The only MHRA-approved format is the pre-filled KwikPen device, available from registered pharmacies like Cured Pharmacy from £124.99 following clinical assessment.
Is the mounjaro vial vs pen format difference significant for weight loss results?
The active ingredient (tirzepatide) is identical, but the KwikPen's precise dosing and convenience support better adherence, which directly impacts weight loss outcomes. All clinical trial data demonstrating 15-22.5% average weight loss used the pen format.
Why doesn't the UK have mounjaro vial options like some other countries?
Eli Lilly, Mounjaro's manufacturer, has only pursued UK licensing for the KwikPen format, which offers superior convenience and safety features. The company's regulatory strategy focuses on the pen delivery system proven in clinical trials.
Would mounjaro vial format be cheaper than the pen in the UK?
This comparison is theoretical as vials aren't available through licensed UK channels. The KwikPen's transparent pricing (from £124.99 at Cured Pharmacy) includes all necessary components, whilst vials would require separate syringes and needles, offsetting potential savings.
How do I use the Mounjaro KwikPen compared to a vial and syringe?
The KwikPen is significantly simpler: attach a new needle, dial your prescribed dose, inject subcutaneously, and dispose of the entire device. No drawing, measuring, or separate components required, reducing injection time to under 30 seconds.
Are mounjaro vial vs pen safety profiles different?
The medication's side effects (nausea, diarrhoea, decreased appetite) are identical, but the KwikPen reduces contamination risk and needlestick injury potential through its sealed, single-use design with automatic needle shield.
Can I switch between mounjaro vial and pen formats during treatment?
In the UK, this isn't applicable as only the KwikPen format is available. Patients remain on the pen format throughout their treatment journey, with dose adjustments made by increasing or decreasing the dialled amount as clinically appropriate.
Where can I buy genuine Mounjaro KwikPen in the UK?
Purchase Mounjaro exclusively through UK-registered pharmacies like Cured Pharmacy (GPhC 9012511) following online clinical assessment. Prices start from £124.99 with £20 off first orders using code Weightlossnew, including discreet delivery within 24-48 hours.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 11 September 2026

Last updated on 11 September 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 11 September 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (11 September 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.